300149 Stock Overview
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ChemPartner PharmaTech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.08 |
| 52 Week High | CN¥9.30 |
| 52 Week Low | CN¥3.68 |
| Beta | 0.63 |
| 11 Month Change | 34.22% |
| 3 Month Change | 53.54% |
| 1 Year Change | -30.03% |
| 33 Year Change | -60.88% |
| 5 Year Change | -60.57% |
| Change since IPO | -58.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300149 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 42.1% | 16.7% | 15.4% |
| 1Y | -30.0% | -18.4% | -7.9% |
Return vs Industry: 300149 underperformed the CN Biotechs industry which returned -23.7% over the past year.
Return vs Market: 300149 underperformed the CN Market which returned -12.3% over the past year.
Price Volatility
| 300149 volatility | |
|---|---|
| 300149 Average Weekly Movement | 13.6% |
| Biotechs Industry Average Movement | 6.0% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.5% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 300149's share price has been volatile over the past 3 months.
Volatility Over Time: 300149's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,916 | Swee Lian Woo | www.cppt.com.cn |
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.
ChemPartner PharmaTech Co.,Ltd. Fundamentals Summary
| 300149 fundamental statistics | |
|---|---|
| Market cap | CN¥3.03b |
| Earnings (TTM) | -CN¥949.07m |
| Revenue (TTM) | CN¥1.05b |
2.9x
P/S Ratio-3.2x
P/E RatioIs 300149 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300149 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.05b |
| Cost of Revenue | CN¥836.67m |
| Gross Profit | CN¥209.40m |
| Other Expenses | CN¥1.16b |
| Earnings | -CN¥949.07m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.91 |
| Gross Margin | 20.02% |
| Net Profit Margin | -90.73% |
| Debt/Equity Ratio | 5.9% |
How did 300149 perform over the long term?
See historical performance and comparison